Key Highlights
- ObjectiveHealth secures a significant investment from Vitruvian Partners, marking a pivotal step in expanding its innovative clinical research model.
- The company’s proprietary AI-driven technology revolutionizes patient recruitment and trial management, setting new standards in clinical research efficiency.
- ObjectiveHealth’s expansion includes the launch of its 30th research center and advanced platforms like ObjectiveScreen and ObjectiveView, fortifying its leadership in the industry.
Source: Business Wire
Notable Quotes
- “We are delighted to have gained the partnership of Vitruvian, whose team has a wealth of knowledge in supporting the rapid growth in companies like ObjectiveHealth,” – Colleen Hoke, CEO at ObjectiveHealth
- “These are exciting times for clinical research, and ObjectiveHealth is at the forefront of delivering a new research model that helps address some of our industry’s biggest challenges,” – Dr. Don Lazas, Co-founder and Chief Medical Officer at ObjectiveHealth
- “Under Colleen and Don’s leadership, ObjectiveHealth has built an innovative and disruptive platform for advancing clinical research,” – Sophie Bower-Straziota, Partner at Vitruvian
SoH's Take
The strategic partnership between ObjectiveHealth and Vitruvian Partners is a testament to the transformative potential of integrating advanced AI-driven technology in clinical research. This collaboration not only amplifies ObjectiveHealth’s capability to optimize the clinical trial process but also marks a significant leap in advancing patient-centric healthcare solutions. With this growth investment, ObjectiveHealth is well-positioned to lead the charge in the era of precision medicine, offering a more efficient and inclusive approach to clinical trials, ultimately accelerating the delivery of innovative treatment options to patients worldwide. The expansion of ObjectiveHealth’s operations and technology platforms signifies a pivotal moment in the evolution of clinical research, setting a new benchmark for excellence and collaboration in the healthcare sector.
